MedPath

Investigation of Methylene Blue for treatment of COVID-19 outpatients referred to pulmonary clinic.

Phase 4
Recruiting
Conditions
COVID-19.
U07.1
COVID-19,
Registration Number
IRCT20191228045924N2
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
240
Inclusion Criteria

Outpatient COVID-19 patients who confirmed by PCR or HRCT referred to pulmonary clinic
SPO2 is between 70-96 after taking off the mask

Exclusion Criteria

Pregnancy
Severe impairment of liver and heart
Renal insufficiency including severe renal impairment
G6PD enzyme deficiency

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath